financetom
Personal Finance
financetom
/
Personal Finance
/
Narayana Health looks forward to IRDAI approval for insurance business by end of 2023
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Narayana Health looks forward to IRDAI approval for insurance business by end of 2023
Sep 14, 2023 7:19 AM

Bangalore-based multispecialty hospital chain Narayana Hrudayalaya Ltd or Narayana Health has taken significant strides towards diversifying its portfolio by submitting an application to the Insurance Regulatory and Development Authority of India (IRDAI) for its bundled insurance plans.

This strategic move aims to bridge the gap between healthcare services and insurance, bringing more comprehensive and integrated solutions to patients and healthcare customers.

Viren Shetty, the Executive Vice-Chairman of Narayana Health, in an interview with CNBC-TV18, said that the group is soon expecting the approval for its insurance business, to be started by the end of the calendar year 2023.

Narayana Health's vision of an integrated healthcare and insurance system is a promising development in the Indian healthcare industry. It has the potential to redefine how healthcare services are accessed and financed.

“Our idea for health insurance is one that combines a huge amount of healthcare services on one end, as well as providing a plan that covers comprehensive health care,” Shetty said.

This approach represents a paradigm shift in the way healthcare and insurance are traditionally perceived and offered.

While the timeline for IRDAI approval remains contingent on regulatory processes, he said, “This calendar year is the hope but more likely it will be by the time we are ready to roll this out by the end of the fiscal year or sometime next calendar year.”

Additionally, the integration of healthcare services and insurance can contribute to better health outcomes. Patients may have access to a wider range of preventive and diagnostic services, resulting in early detection and treatment of health issues. This proactive approach aligns with Narayana Health's mission of promoting overall well-being and longevity.

The company has recently launched a new logo and is currently engaged in a rebranding campaign with the aim of consolidating all its portfolios under a single name, a shared mission, and a common purpose. According to Shetty, this rebranding effort involves bringing all the hospitals under the Narayana brand, promoting unity.

Founded by Dr Devi Shetty, a well known heart surgeon, Narayana Health has a network of 24 hospitals across India at present. This includes several multispecialty hospitals, 7 heart hospitals and a couple of eye hospitals.

For more details, watch the accompanying video

Also, catch all the live updates on markets with CNBC-TV18.com's blog

(Edited by : C H Unnikrishnan)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Reiterates Buy Opinion On The Goldman Sachs Group, Inc.
Research Alert: CFRA Reiterates Buy Opinion On The Goldman Sachs Group, Inc.
Apr 13, 2026
12:05 PM EDT, 04/13/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our $1,000 target using a forward P/E of 16.1x, which is above the average five-year historical P/E at 15.5x on normalized earnings. We raise our 2026 EPS estimate...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Rpm International Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Rpm International Inc.
Apr 13, 2026
12:15 PM EDT, 04/13/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We decrease our 12-month target price by $3 to $127, or 20.4x our FY27 (May) EPS estimate, which is in line with RPM's three-year average forward P/E of 20.5x. We...
Research Alert: CFRA Retains Buy Opinion On Shares Of Johnson & Johnson
Research Alert: CFRA Retains Buy Opinion On Shares Of Johnson & Johnson
Apr 14, 2026
10:40 AM EDT, 04/14/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our target of $278, 22.1x our 2027 EPS view, above JNJ's 10-year historical forward P/E average, justified by its improving growth outlook. We lift our 2026 EPS view...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Wells Fargo & Company
Research Alert: CFRA Keeps Buy Opinion On Shares Of Wells Fargo & Company
Apr 14, 2026
12:05 PM EDT, 04/14/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: With higher inflation expectations and a weakening low-end consumer, we cut our 12-month target price by $10 to $108, representing 13.3x our 2027 EPS estimate, above the five-year historical average...
Copyright 2023-2026 - www.financetom.com All Rights Reserved